PI: Dr. Mollie Monnig
Probiotics to Reduce Systemic and Neural Inflammation in Heavy Drinkers
This project is a 30-day, open-label clinical trial of probiotics as an intervention to reduce systemic and neural inflammation in heavy drinkers. The study will recruit 15 non-treatment-seeking heavy drinkers to complete the pre/post design. Main outcomes are plasma biomarkers of immune activation and brain metabolites associated with neuroinflammation.